韻達股份(002120.SZ)擬5000萬-1億元回購股份 回購價格不超14元/股
格隆匯11月19日丨韻達股份(002120.SZ)發佈公吿,公司擬使用自有資金通過深圳證券交易所股票交易系統以集中競價交易方式回購公司股票,回購的股份將用於股權激勵計劃或員工持股計劃。回購資金總額為人民幣5000萬元(含)-1億元(含),回購價格為不超過人民幣14元/股。
在回購股份價格不超過人民幣14元/股的條件下,按回購金額上限測算,預計回購股份數量約為714.29萬股;按回購金額下限測算,預計回購股份數量約為357.14萬股,具體回購股份數量以回購期滿時或實施完畢時實際回購股份數量為準。本次回購期限自公司董事會審議通過回購方案之日起不超過6個月。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.